ES2149357T3 - Procedimiento y sales diastereomeras utiles para la resolucion optica del acido 4-(4-((hidroxidifenilmetil)-1-piperidinil)-1-hidroxibutil)-alfa,alfa-dimetilbenceno acetico racemico. - Google Patents

Procedimiento y sales diastereomeras utiles para la resolucion optica del acido 4-(4-((hidroxidifenilmetil)-1-piperidinil)-1-hidroxibutil)-alfa,alfa-dimetilbenceno acetico racemico.

Info

Publication number
ES2149357T3
ES2149357T3 ES95916294T ES95916294T ES2149357T3 ES 2149357 T3 ES2149357 T3 ES 2149357T3 ES 95916294 T ES95916294 T ES 95916294T ES 95916294 T ES95916294 T ES 95916294T ES 2149357 T3 ES2149357 T3 ES 2149357T3
Authority
ES
Spain
Prior art keywords
alfa
acid
hidroxidifenilmetil
hidroxibutil
piperidinil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95916294T
Other languages
English (en)
Inventor
Mitsuo Nakamura
Masatoshi Shiga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2149357T3 publication Critical patent/ES2149357T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

PROCESO Y SALES DIAESTEREOMERICAS UTILES PARA LA RESOLUCION OPTICA DE LOS COMPUESTOS RACEMICOS {AL}-[4-(1,1DIMETILETIL)FENIL]-4-(HIDROXIDIFENILMETIL)-1-PIPERIDINBUTANOL, ACIDO 4-[4-[4-(HIDROXIFENILMETIL)-1-PIPERIDINIL]-1HIDROXIBUTIL)]-{AL},{AL}-DIMETILBENCENOACETICO Y 4-[4-[4-(HIDROXIFENILMETIL)-1-PIPERIDINIL]-1-HIDROXIBUTIL)]{AL},{AL}-DIMETILBENCENOACETATOS DE ALQUILO INFERIOR. EL PROCESO COMPRENDE PONER EN UNA SOLUCION UN AGENTE DE RESOLUCION QUIRAL, BIEN ACIDO (+)/(-)-DI-PARATOLUILTARTARICO O ACIDO (-)/(+)MANDELICO, EN UNA CANTIDAD EQUIMOLAR A UN COMPUESTO QUE CORRESPONDE AL ENANTIOMERO DESEADO DEL COMPUESTO ANTES MENCIONADO, PRECIPITANDO LA SAL DIASTEREOMERICA RESULTANTE ENTRE EL AGENTE DE RESOLUCION QUIRAL Y EL ENANTIOMERO OBJETO Y FINALMENTE SEPARANDO EL ENENTIOMERO.
ES95916294T 1994-05-16 1995-04-10 Procedimiento y sales diastereomeras utiles para la resolucion optica del acido 4-(4-((hidroxidifenilmetil)-1-piperidinil)-1-hidroxibutil)-alfa,alfa-dimetilbenceno acetico racemico. Expired - Lifetime ES2149357T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24291994A 1994-05-16 1994-05-16

Publications (1)

Publication Number Publication Date
ES2149357T3 true ES2149357T3 (es) 2000-11-01

Family

ID=22916643

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95916294T Expired - Lifetime ES2149357T3 (es) 1994-05-16 1995-04-10 Procedimiento y sales diastereomeras utiles para la resolucion optica del acido 4-(4-((hidroxidifenilmetil)-1-piperidinil)-1-hidroxibutil)-alfa,alfa-dimetilbenceno acetico racemico.

Country Status (21)

Country Link
US (3) US20030078429A1 (es)
EP (1) EP0759904B1 (es)
JP (1) JPH10503752A (es)
KR (1) KR100387459B1 (es)
CN (3) CN100369897C (es)
AT (1) ATE194328T1 (es)
AU (1) AU689578B2 (es)
CA (1) CA2189000C (es)
DE (1) DE69517810T2 (es)
DK (1) DK0759904T3 (es)
ES (1) ES2149357T3 (es)
FI (1) FI114095B (es)
GR (1) GR3034444T3 (es)
IL (1) IL113738A (es)
MX (1) MX9605611A (es)
NO (1) NO308031B1 (es)
NZ (1) NZ284277A (es)
PT (1) PT759904E (es)
TW (1) TW424085B (es)
WO (1) WO1995031436A1 (es)
ZA (1) ZA953793B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9805870A (es) * 1996-01-22 1999-01-31
US6242464B1 (en) 1996-01-22 2001-06-05 Chiroscience Limited Single isomer methylphenidate and resolution process
US5925761A (en) * 1997-02-04 1999-07-20 Sepracor Inc. Synthesis of terfenadine and derivatives
DE10145223A1 (de) * 2001-09-13 2003-04-03 Basf Ag Verfahren zur Herstellung von meso-Zeaxanthin
ITMI20041568A1 (it) * 2004-07-30 2004-10-30 Dipharma Spa "polimorfi di fexofenadina base"
MX2008011714A (es) 2006-03-14 2008-11-12 Univ Southern California Dispositivo de mems y metodo de administracion de agentes terapeuticos.
MX364408B (es) 2007-12-20 2019-04-25 Univ Southern California Aparatos y metodos para suministrar agentes terapeuticos.
US9849238B2 (en) 2008-05-08 2017-12-26 Minipumps, Llc Drug-delivery pump with intelligent control
WO2009137785A2 (en) 2008-05-08 2009-11-12 Replenish Pumps, Llc Drug-delivery pumps and methods of manufacture
EP2320989B1 (en) 2008-05-08 2015-03-11 MiniPumps, LLC Implantable pumps and cannulas therefor
US9115052B2 (en) * 2009-01-16 2015-08-25 Basf Se Separation of an enantiomer mixture of (R)- and (S)-3-amino-1-butanol
AU2010284216B2 (en) 2009-08-18 2015-10-15 Minipumps, Llc Electrolytic drug-delivery pump with adaptive control
CN103497145B (zh) * 2013-10-10 2016-01-27 南昌大学 一种光学纯多奈哌齐的制备工艺
CN112739686B (zh) * 2018-09-28 2024-10-18 赛特瑞恩股份有限公司 用于制备(-)-西苯唑啉琥珀酸盐的新方法
MX2022004467A (es) * 2019-10-17 2022-05-03 Bayer Ag Procedimiento para preparar (4s)-4-(4-ciano-2-metoxi-fenil)-5-etox i-2,8-dimetil-1,4-dihidro-1,6-naftiridin-3-carboxilato de 2-cianoetilo mediante separacion de racematos utilizando esteres diastereomericos de acido tartarico.
EP4045499A1 (de) * 2019-10-17 2022-08-24 Bayer Aktiengesellschaft Verfahren zur herstellung von 2-cyanoethyl (4s)-4-(4-cyano-2-methoxy-phenyl)-5-hydroxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridin-3-carboxylat durch racemat-spaltung mittels diastereomerer weinsäureester

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3452086A (en) * 1966-04-29 1969-06-24 Bristol Myers Co Substituted tartranilic acid resolving agents
IT951631B (it) * 1971-03-18 1973-07-10 Richardson Merrell Spa Composti utili per la separazione di isomeri ottici geometrici e strutturali e relativo procedimen to di sintesi
US3878217A (en) * 1972-01-28 1975-04-15 Richardson Merrell Inc Alpha-aryl-4-substituted piperidinoalkanol derivatives
FR2201108B1 (es) * 1972-09-25 1977-12-23 Copier Henri
US4128663A (en) * 1977-03-15 1978-12-05 The Upjohn Company Anilide derivatives as antidepressants
US4254129A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4285957A (en) * 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkanol derivatives, pharmaceutical compositions thereof, and method of use thereof
EP0108817A1 (en) * 1982-11-06 1984-05-23 Kanegafuchi Chemical Industry Co., Ltd. Stable composition of S-adenosyl-L-methionine and process for preparation thereof
JPS59210086A (ja) * 1983-05-13 1984-11-28 Kyowa Hakko Kogyo Co Ltd Ｄｘ―５２―１類及びその塩類
US5011989A (en) * 1987-10-09 1991-04-30 Sumitomo Chemical Company, Limited Optically active hydroxybenzylamine
US4931557A (en) * 1988-10-17 1990-06-05 Eli Lilly And Company Method of resolving cis 3-amino-4-(2-furyl)vinyl)-1-methoxycarbonylmethyl-azetidin-2-one and di-p-toluoyl-tartaric acid salts thereof
US4968837A (en) * 1989-07-28 1990-11-06 Ethyl Corporation Resolution of racemic mixtures

Also Published As

Publication number Publication date
DE69517810D1 (de) 2000-08-10
US20040186137A1 (en) 2004-09-23
US20060014793A1 (en) 2006-01-19
CN1309121A (zh) 2001-08-22
CN1740156A (zh) 2006-03-01
HK1039485A1 (en) 2002-04-26
US20030078429A1 (en) 2003-04-24
CA2189000C (en) 2002-08-13
DK0759904T3 (da) 2000-10-02
FI964566L (fi) 1996-11-14
MX9605611A (es) 1998-05-31
GR3034444T3 (en) 2000-12-29
ZA953793B (en) 1996-01-19
ATE194328T1 (de) 2000-07-15
CA2189000A1 (en) 1995-11-23
CN100369897C (zh) 2008-02-20
NO964858L (no) 1997-01-15
WO1995031436A1 (en) 1995-11-23
TW424085B (en) 2001-03-01
IL113738A0 (en) 1995-08-31
AU2284095A (en) 1995-12-05
DE69517810T2 (de) 2000-12-14
KR100387459B1 (ko) 2003-11-20
CN1229346C (zh) 2005-11-30
FI114095B (fi) 2004-08-13
AU689578B2 (en) 1998-04-02
PT759904E (pt) 2000-10-31
NO964858D0 (no) 1996-11-15
NZ284277A (en) 1998-01-26
IL113738A (en) 2003-10-31
CN1148382A (zh) 1997-04-23
CN1119330C (zh) 2003-08-27
EP0759904A1 (en) 1997-03-05
FI964566A0 (fi) 1996-11-14
JPH10503752A (ja) 1998-04-07
HK1088603A1 (zh) 2006-11-10
NO308031B1 (no) 2000-07-10
EP0759904B1 (en) 2000-07-05

Similar Documents

Publication Publication Date Title
ES2149357T3 (es) Procedimiento y sales diastereomeras utiles para la resolucion optica del acido 4-(4-((hidroxidifenilmetil)-1-piperidinil)-1-hidroxibutil)-alfa,alfa-dimetilbenceno acetico racemico.
IS7842A (is) Meðferð á fettubrettusýki með eikósapentanósýru (EPA)
UA26334A (uk) Спосіб дезиhфекції коhтактhих ліhз та композиція для дезиhфекції коhтактhих ліhз
EP1664851A4 (en) THREE-DIMENSIONAL SIMULTANEOUS SURFACE PROCESSING AND RELATED FREIFORM LIGHTING OPTICS
ES2147569T3 (es) Enantiomeros de la 1-((4-clorofenil)fenilmetil)-4-((4-metilfenil)sulfonil)piperazina.
PT782569E (pt) Processo de racemizacao utilizado no fabrico de levobupivacaina e seus analogos
ATE279920T1 (de) Stabile infusionslösung von diclofenac-salzen, deren herstellung und verwendung
ES2022448B3 (es) Composicion desinfectante para lentes de contacto blandas, que contienen una disolucion de peroxido de hidrogeno estabilizada.
IL142669A0 (en) Method for racemate splitting of 2-hydroxypropionic acids
ES2079127T3 (es) Composicion herbicida.
ES2094227T3 (es) Procedimiento para la preparacion de una suspension acuosa.
FR2610627B1 (fr) Sels cristallins de l'acide (3s(z))-2(((1-(2-amino-4-thiazolyl)-2-((2,2-dimethyl-4-oxo-1-(sulfo-oxy)-3-azetidinyl)amino)-2-oxoethylidene)-amino)oxy)acetique, a action therapeutique
DE69707928D1 (de) Herstellung von dinatrium-ethylendiamin-n,n'-disuccinat
ES2129746T3 (es) Procedimiento para la preparacion de los enantiomeros del acido 2-(2-fluoro-4-difenil)propionico.
NO972291L (no) Fremgangsmåte for fremstilling av optisk aktive forbindelser
FR2760452B1 (fr) Procede d'obtention d'enantiomeres d'acides alpha-amines et sels diastereoisomeriques intermediaires
DE3764701D1 (de) N-((trimethoxy-2,4,6-benzoyl)-3-propyl)piperidin-derivate, verfahren zu ihrer herstellung und deren anwendung als heilmittel.
FI930751A0 (fi) Foerfarande foer omvandlande av r(-) 2-(3-bensoylfenyl)propionsyra till s(+) -isomer
NO972290L (no) Fremgangsmåte for fremstilling av optisk aktive forbindelser
FI914116A0 (fi) Menetelmä 2,2-dimetyylisyklopropaanikarboksyylihapon rasemaattipilkkomiseksi
EE02938B1 (et) p-hüdroksübensoehappe derivaadid, nende valmistamismeetod ja kasutamine ravimitena
HUT46893A (en) Process for production of optically clean 5-/-/-1-prophil-2-6'-pipecoloxilidid-hydrochlorid
YU43530B (en) Process for obtaining new racemic and optic active 1-(2,4-dichlorophenoxy)-3-(3,4-dimethoxy-beta-phenethyl-amino)-propanol-(2)
JPS6431703A (en) Mold removing agent and method for removing and preventing mold
RU95120762A (ru) Способ лечения острого ринофаринголарингита

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 759904

Country of ref document: ES